Circulating naive and memory CD4+ T cells and metabolic syndrome in patients with systemic lupus erythematosus: data from a primarily Mestizo population.

@article{UgarteGil2015CirculatingNA,
  title={Circulating naive and memory CD4+ T cells and metabolic syndrome in patients with systemic lupus erythematosus: data from a primarily Mestizo population.},
  author={Manuel Francisco Ugarte-Gil and C{\'e}sar S{\'a}nchez-Z{\'u}{\~n}iga and Rocio V Gamboa-C{\'a}rdenas and Madeley Aliaga-Zamudio and Francisco Zevallos and Giannina Tineo-Pozo and Jorge M. Cucho-Venegas and Ana Mosqueira-Riveros and Risto Alfredo Perich-Campos and Jos{\'e} L. Alfaro-Lozano and Mariela Medina and Zoila J. Rodr{\'i}guez-Bellido and Graciela S Alarc{\'o}n and Cesar Augusto Pastor-Asurza},
  journal={Rheumatology},
  year={2015},
  volume={54 7},
  pages={
          1302-7
        }
}
OBJECTIVE The aim of this study was to determine whether the proportions of naive and memory CD4(+) T cell are independently associated with the metabolic syndrome (MetS) in patients with SLE. METHODS This cross-sectional study was conducted in SLE patients seen at our rheumatology department between September 2013 and April 2014. CD4(+) T cell subpopulations were examined by flow cytometry. The association of MetS and CD4(+) T cell subpopulations was examined by Mann-Whitney U-test and by… 
View on PubMed
academic.oup.com
16 Citations
Background Citations
2
Results Citations
2

16 Citations

Citation Type

Citation Type

Association of the premature immunosenescence with the presence and severity of anemia among patients with systemic lupus erythematosus
TLDR
Investigation in women with SLE found that immunosenescence is associated with anemia by modulating the inflammatory response and causing iron dysregulation in SLE.
Analysis of CD95 and CCR7 expression on circulating CD4+ lymphocytes revealed disparate immunoregulatory potentials in systemic lupus erythematosus
The association between metabolic syndrome and its components with systemic lupus erythematosus: a comprehensive systematic review and meta-analysis of observational studies
TLDR
The risk of MetS was significantly higher in SLE patients, compared with healthy controls, even after adjusting for publication bias, and high TG and high BP were most strongly associated with SLE.
High Prevalence of Metabolic Syndrome in South African Systemic Lupus Erythematosus Patients
TLDR
This study shows a high prevalence of metabolic syndrome amongst South Africans with recently diagnosed SLE and calls for aggressive strategies to reduce the prevalence of MetS and atherosclerotic cardiovascular disease.
Effect of the metabolic syndrome on organ damage and mortality in patients with systemic lupus erythematosus: a longitudinal analysis.
TLDR
The MetS is significantly associated with new organ damage, vascular events and mortality in patients with SLE and significantly increased the risk of new vascular events after adjustment for the same covariates.
Reduced T-Cell Thymic Export Reflected by sj-TREC in Patients with Coronary Artery Disease.
TLDR
Impaired RTE could be partly responsible for CAD development and Mechanisms may be involved in the disturbance of T lymphocyte compartment and interruption of maintained immune tolerance resulting from thymus involution.
Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking “Inflammaging” in Patients with Systemic Lupus Erythematosus
TLDR
The molecular and cellular bases of inflammaging and cardiovascular complications in SLE patients will be extensively reviewed from the aspects of mitochondrial dysfunctions, abnormal bioenergetics/immunometabolism, and telomere/telomerase disequilibrium.
Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach
TLDR
Clinicians should consider socioeconomic status and medication and seek to modify disease activity, MetS, and depression to improve the HRQOL of SLE patients.
A web visualization tool using T cell subsets as the predictor to evaluate COVID-19 patient's severity
TLDR
The findings suggest that while age and underlying diseases are known risk factors for poor prognosis, patients with a less damaged immune system at the time of hospitalization had higher chance of recovery.
Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?
TLDR
Current evidence supports a role for immune dysregulation, epigenetic modifications, cellular senescence, mitochondrial dysregulation and impaired autophagy in fibrosis in aging and SSc.
...
1
2
...

References

SHOWING 1-10 OF 26 REFERENCES
Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort
TLDR
Renal lupus, higher corticosteroid doses, Korean and Hispanic ethnicity, and immunosuppressant use are associated with MetS in SLE patients, andBalancing disease control and minimising cortICosteroid exposure should be at the forefront of personalised treatment decisions in Sle patients.
Decreased Naive and Increased Memory CD4+ T Cells Are Associated with Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis
TLDR
It is demonstrated that the degree of chronic adaptive immune activation is associated with both CAC and CC IMT in otherwise healthy individuals, consistent with the known role of CD4+ T cells, and with innate immunity (inflammation), in atherosclerosis.
The levels of memory (CD45RA−, RO+) CD4+ and CD8+ peripheral blood T-lymphocytes correlate with IgM rheumatoid factors in rheumatoid arthritis
TLDR
In RA, the proportions of memory CD4+ and CD8+ T-PBL correlate with the level of IgM-RF and, together with transient T-pBL, with clinical parameters of disease activity and outcome.
A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.
TLDR
A deficiency exists in SLE patients with active renal disease in the T4+2H4+ suppressor-inducer T cell subset, which is shown to be critical for the activation of T8+ suppressing cells in systemic lupus erythematosus patients.
Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models
TLDR
Circulating TEM cells are associated with increased atherosclerosis and coronary artery disease in humans and in animal models and could represent a key CD4+T-cell subset related to the atherosclerotic process.
FRI0426 High Prevalence of Overweight and Obesity in Recently Diagnosed Systemic Lupus Erythematosus Patients in an International Registry
TLDR
The prevalence of overweight and obesity in a cross-sectional cohort of early SLE patients and factors associated with overweight in this population was examined and no association with disease activity, therapy or self-reported physical activity was found.
Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.
An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus
TLDR
It is shown that MetS is more prevalent in SLE, but the lupus-MetS phenotype reflects risk factor changes driven by disease activity and steroid exposure, rather than obesity, and continued attention to individual CHD risk factors is recommended.
Active systemic lupus erythematosus is associated with the recruitment of naive/resting T cells.
TLDR
The recruitment of resting T cells in active SLE, rather than the simple reactivation of existing memory clones, has implications for understanding the pathology of this disease and for treating it.
Quantitative defect of CD4+2H4+ cells in systemic lupus erythematosus and Sjögren's syndrome.
TLDR
Surface antigens of T lymphocytes in peripheral blood mononuclear cells from 19 patients with systemic lupus erythematosus, 14 patients with Sjögren's syndrome, and 14 healthy control subjects suggest that quantitative defect of suppressor/inducer cells may play an important role in the immunoregulatory disturbance in SLE and SS.
...
1
2
3
...